Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 27 Prostatic Neoplasms 26 Brain Neoplasms 23 Lung Neoplasms 17 Neoplasm Metastasis 15 Breast Neoplasms 12 Melanoma 9 Carcinoma, Renal Cell 8 Pancreatic Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Neoplasms 3 NSCLC 3 Meningioma 3 Gastrointestinal Neoplasms 3 Unresectable Locally Recurrent Rectal Cancer 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Epidural Neoplasms 2 Carcinoma, Transitional Cell 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1

Interventions

Bevacizumab 2 neratinib 1 brigatinib 1 Sufentanil 1 Radiosurgery 1 Cochlear Implants 1 ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma, Acoustic × Radiosurgery × 90 days × Clear all

NCT05702749 2026-03-24

VS PREHAB

Medical College of Wisconsin

Phase NA Recruiting

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡